ArticleDiagnostic pathology2014
AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.
Yuantong Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papercites it
ArticleDiagnostic pathology2014
Yuantong Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.